Beibei Guo Selected Research

Beibei Guo Research Topics

Disease

28	Neoplasms (Cancer) 01/2024 - 01/2016
7	Breast Neoplasms (Breast Cancer) 01/2023 - 07/2018
6	AIDS-Related Complex (ARC) 04/2022 - 07/2018
5	Neoplasm Metastasis (Metastasis) 01/2023 - 02/2020
4	Acute-On-Chronic Liver Failure 03/2024 - 06/2020
3	Inflammation (Inflammations) 03/2024 - 01/2022
3	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 03/2024 - 01/2022
2	Triple Negative Breast Neoplasms 07/2023 - 01/2022
2	Asthma (Bronchial Asthma) 01/2023 - 01/2022
2	Melanoma (Melanoma, Malignant) 10/2022 - 10/2021
2	Bites and Stings (Sting) 10/2022 - 01/2022
2	Wounds and Injuries (Trauma) 08/2022 - 01/2021
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 04/2020
2	Unilateral Breast Neoplasms 12/2020 - 04/2020
2	Hepatocellular Carcinoma (Hepatoma) 10/2020 - 01/2020
1	Constipation 03/2024
1	Fatigue 03/2024
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 03/2024
1	Weight Gain 03/2024
1	Pathologic Processes 01/2024
1	Prostatic Neoplasms (Prostate Cancer) 10/2023
1	Fibrosis (Cirrhosis) 10/2023
1	Hepatitis B 01/2023
1	Allergic Rhinitis 01/2023
1	Hypersensitivity (Allergy) 01/2023
1	Liver Failure 01/2023
1	End Stage Liver Disease 01/2023
1	Ovarian Epithelial Carcinoma 09/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2022
1	Hypoxia (Hypoxemia) 08/2022
1	Infarction (Infarctions) 08/2022
1	Disease Progression 01/2022
1	Chronic Hepatitis B 01/2022
1	Glioma (Gliomas) 01/2022
1	Brain Diseases (Brain Disorder) 11/2021
1	Burns 01/2021

Drug/Important Bio-Agent (IBA)

4	DisulfidesIBA 10/2023 - 10/2020
3	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2020
3	Docetaxel (Taxotere)FDA Link 10/2023 - 04/2020
3	CytokinesIBA 01/2023 - 01/2022
3	Peptides (Polypeptides)IBA 01/2022 - 10/2020
2	IntegrinsIBA 10/2023 - 04/2020
2	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2023
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2023 - 01/2022
2	Gemcitabine FDA Link 07/2023 - 01/2022
2	Apolipoproteins E (ApoE)IBA 01/2022 - 10/2020
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2022
2	MicellesIBA 01/2022 - 10/2020
1	Inosine Monophosphate (IMP)IBA 03/2024
1	Thrombospondin 1IBA 03/2024
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2024
1	Arginine Vasopressin (Argipressin)IBA 10/2023
1	A-factor (Streptomyces)IBA 10/2023
1	AllergensIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	LipopolysaccharidesIBA 01/2023
1	HMGB1 Protein (HMG1)IBA 01/2023
1	SodiumIBA 01/2023
1	ADU-S100IBA 10/2022
1	InterferonsIBA 10/2022
1	BI 6727IBA 09/2022
1	lupaneIBA 08/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 08/2022
1	EnzymesIBA 08/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 08/2022
1	Phosphotransferases (Kinase)IBA 08/2022
1	TriterpenesIBA 08/2022
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 08/2022
1	Caspase 3 (Caspase-3)IBA 08/2022
1	acetyl- lysyl- prolyl- seryl- seryl- prolyl- prolyl- glutamyl- glutamic acid amideIBA 01/2022
1	ProdrugsIBA 01/2022
1	CPG-oligonucleotideIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Granzymes (Granzyme)IBA 01/2022
1	MethoxyhydroxyphenylglycolIBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 11/2021
1	BilirubinIBA 11/2021
1	LTX-315IBA 10/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	UCON 50-HB-5100 (F127)IBA 01/2021
1	Polyvinyl AlcoholIBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Bromelains (Bromelain)IBA 01/2021
1	Photosensitizing Agents (Photosensitizers)IBA 01/2021
1	HydrogelsIBA 01/2021

Therapy/Procedure

16	Therapeutics 10/2023 - 01/2016
15	Immunotherapy 01/2024 - 01/2016
8	Radiotherapy 01/2024 - 07/2018
5	Drug Therapy (Chemotherapy) 12/2022 - 01/2018
4	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021 - 01/2020
3	Transplantation 01/2023 - 01/2020
2	Liver Transplantation 03/2023 - 06/2020
2	Mastectomy (Mammectomy) 04/2020 - 01/2020
1	Conservative Treatment 03/2024
1	Radioimmunotherapy 01/2023
1	Adjuvant Chemotherapy 09/2022
1	Intravenous Administration 09/2022